About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.
Browse Other Projects on Experiment
Development of non-invasive diagnostics for endotheliotropic herpesvirus in free-ranging Asian elephants
Elephant endotheliotropic herpes virus hemorrhagic disease (EEHV-HD) is the leading cause of death of young...